ArticlePLoS pathogens2019

ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.

Luca Schifanella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.